RegentAtlantic Capital’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$293K Sell
1,762
-482
-21% -$98.1K 0.01% 564
2022
Q2
$463K Sell
2,244
-124
-5% -$28K 0.02% 454
2022
Q1
$573K Sell
2,368
-175
-7% -$40.6K 0.02% 432
2021
Q4
$619K Buy
2,543
+34
+1% +$7.77K 0.02% 407
2021
Q3
$513K Buy
2,509
+15
+0.6% +$3.21K 0.02% 426
2021
Q2
$515K Buy
+2,494
New +$502K 0.02% 419
2015
Q1
Sell
-45
Closed -$2.92K 860
2014
Q4
$2.92K Buy
+45
New +$2.78K ﹤0.01% 1085

Other funds holding STE

RegentAtlantic Capital's STE Position: Q3 2022 in Review

RegentAtlantic Capital reduced its Steris (STE) stake by 21% in Q3 2022, selling an estimated $98.1K and leaving 1,762 shares worth $293K. The position accounts for 0.01% of the portfolio, ranked #564.

RegentAtlantic Capital first reported a position in STE in Q4 2014 and has held it in 7 quarters since. The position peaked at $619K in Q4 2021. 637 funds tracked by Wall St. Rank hold STE as of Q3 2022.

  • RegentAtlantic Capital held 1,762 shares of Steris worth $293K as of Q3 2022.
  • RegentAtlantic Capital sold 482 Steris shares in Q3 2022, an estimated $98.1K.
  • Steris made up 0.01% of RegentAtlantic Capital's portfolio in Q3 2022, its #564 holding.
  • RegentAtlantic Capital first reported a position in Steris in Q4 2014 and has held it in 7 quarters since.
  • RegentAtlantic Capital's Steris position peaked at $619K in Q4 2021.
  • 637 funds tracked by Wall St. Rank held Steris as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.